The neutrophil-to-lymphocyte ratio at the prostate-specific antigen nadir predicts the time to castration-resistant prostate cancer

被引：1
|
作者：
Iwamoto, Genta [1 ]
Kawahara, Takashi [1 ,2 ]
Yokomizo, Yumiko [2 ]
Miyoshi, Yasuhide [1 ]
Yao, Masahiro [2 ]
Uemura, Hiroji [2 ]
机构：
[1] Yokohama City Univ, Med Ctr, Dept Urol & Renal Transportat, Yokohama, Kanagawa, Japan
[2] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa, Japan
来源：
ASIAN JOURNAL OF UROLOGY | 2021年 / 8卷 / 03期
关键词：
D O I：
10.1016/j.ajur.2020.05.006
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：332 / 334
页数：3
相关论文
共 50 条
  • [31] Prostate-specific antigen response patterns during cabazitaxel therapy in patients with metastatic castration-resistant prostate cancer
    Kanao, Kent
    Ito, Toshiki
    Takahara, Kiyoshi
    Ando, Ryosuke
    Yasui, Takahiro
    Shiroki, Ryoichi
    Miyake, Hideaki
    Sumitomo, Makoto
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (11) : 1043 - 1048
  • [32] Significant associations of prostate-specific antigen nadir and time to prostate-specific antigen nadir with survival in prostate cancer patients treated with androgen-deprivation therapy
    Huang, Shu-Pin
    Bao, Bo-Ying
    Wu, Ming-Tsang
    Choueiri, Toni K.
    Goggins, William B.
    Liu, Chia-Chu
    Huang, Chao-Yuan
    Pu, Yeong-Shiau
    Yu, Chia-Cheng
    Wu, Tony T.
    Huang, Chun-Nung
    Huang, Chun-Hsiung
    Wu, Wen-Jeng
    AGING MALE, 2012, 15 (01): : 34 - 41
  • [33] Prostate-specific antigen kinetics as a surrogate endpoint in clinical trials of metastatic castration-resistant prostate cancer: A review
    Colloca, G.
    CANCER TREATMENT REVIEWS, 2012, 38 (08) : 1020 - 1026
  • [34] Prostate-Specific Antigen Nadir and Time to Prostate-Specific Antigen Nadir Following Maximal Androgen Blockade Independently Predict Prognosis in Patients with Metastatic Prostate Cancer
    Hong, Seok Young
    Cho, Dae Sung
    Kim, Sun Il
    Ahn, Hyun Soo
    Kim, Se Joong
    KOREAN JOURNAL OF UROLOGY, 2012, 53 (09) : 607 - 613
  • [35] ASSOCIATION OF PROSTATE-SPECIFIC ANTIGEN TRAJECTORIES WITH MORTALITY IN VETERANS WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Freedland, Stephen
    Young-Xu, Yinong
    Li, Sophia
    Pilon, Dominic
    Bhak, Rachel
    Duchesneau, Emilie
    Hellstern, Michael
    Behl, Ajay
    Lefebvre, Patrick
    Fuld, Alexander
    JOURNAL OF UROLOGY, 2019, 201 (04): : E497 - E498
  • [36] Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer
    Fendler, Wolfgang P.
    Weber, Manuel
    Iravani, Amir
    Hofman, Michael S.
    Calais, Jeremie
    Czernin, Johannes
    Ilhan, Harun
    Saad, Fred
    Small, Eric J.
    Smith, Matthew R.
    Perez, Paola M.
    Hope, Thomas A.
    Rauscher, Isabel
    Londhe, Anil
    Lopez-Gitlitz, Angela
    Cheng, Shinta
    Maurer, Tobias
    Herrmann, Ken
    Eiber, Matthias
    Hadaschik, Boris
    CLINICAL CANCER RESEARCH, 2019, 25 (24) : 7448 - 7454
  • [37] Narrative review: prostate-specific membrane antigen-radioligand therapy in metastatic castration-resistant prostate cancer
    Lunger, Lukas
    Tauber, Robert
    Feuerecker, Benedikt
    Gschwend, Jurgen E.
    Eiber, Matthias
    Heck, Matthias M.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (10) : 3963 - 3971
  • [38] Understanding prostate-specific antigen dynamics in monitoring metastatic castration-resistant prostate cancer: implications for clinical practice
    Mizokami, Atsushi
    Izumi, Kouji
    Konaka, Hiroyuki
    Kitagawa, Yasuhide
    Kadono, Yoshifumi
    Narimoto, Kazutaka
    Nohara, Takahiro
    Bahl, Amit K.
    Namiki, Mikio
    ASIAN JOURNAL OF ANDROLOGY, 2017, 19 (02) : 143 - 148
  • [39] Prostate-Specific Antigen Flare Induced by (223)Ra therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
    Castello, A.
    Macapinlac, H. A.
    Santos, E. B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S211 - S211
  • [40] PROSTATE-SPECIFIC ANTIGEN NADIR AND TIME TO PROSTATE-SPECIFIC ANTIGEN NADIR FOLLOWING MAXIMAL ANDROGEN BLOCKADE INDEPENDENTLY PREDICT THE PROGNOSIS IN PATIENTS WITH METASTATIC PROSTATE CANCER
    Sun, I
    Seok, Y.
    Dea, S.
    Hyun, S.
    Young, S.
    Se, J.
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 362 - 362
12345